Data / Form D filings / Capacity Bio, Inc.
Capacity Bio, Inc.: Form D filing
Capacity Bio, Inc., a pharmaceuticals company in Palo Alto, CA, filed a Form D with the SEC in 2023. The latest, on January 18, 2023, reports $19.2 million sold of a $35.3 million offering to 13 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3175 HANOVER ST., Palo Alto, CA, 94304
- Phone
- (650) 814-1639
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1960587
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 18, 2023 | New notice | $35,329,982 | $19,210,937 | $16,119,045 | 13 | Dec 21, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kenneth Horne | Executive Officer, Director | |
| Taro Inaba | Director | |
| Dylan Morris | Director | |
| Amy Wang | Executive Officer, Director | |
| Cristina Ghenoiu | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Jan 16, 2023 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Capacity Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.